These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 29491867)

  • 1. Acquired Natural Killer Cell Dysfunction in the Tumor Microenvironment of Classic Hodgkin Lymphoma.
    Chiu J; Ernst DM; Keating A
    Front Immunol; 2018; 9():267. PubMed ID: 29491867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation of the Immunosuppressive Microenvironment of Classic Hodgkin Lymphoma and Therapeutic Approaches to Counter It.
    Aldinucci D; Borghese C; Casagrande N
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31096713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The circuitry of the tumor microenvironment in adult and pediatric Hodgkin lymphoma: cellular composition, cytokine profile, EBV, and exosomes.
    Nagpal P; Descalzi-Montoya DB; Lodhi N
    Cancer Rep (Hoboken); 2021 Apr; 4(2):e1311. PubMed ID: 33103852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The microenvironment in classical Hodgkin lymphoma: an actively shaped and essential tumor component.
    Liu Y; Sattarzadeh A; Diepstra A; Visser L; van den Berg A
    Semin Cancer Biol; 2014 Feb; 24():15-22. PubMed ID: 23867303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of tumor cells escaping from immune surveillance of NK cells.
    Ge Z; Wu S; Zhang Z; Ding S
    Immunopharmacol Immunotoxicol; 2020 Jun; 42(3):187-198. PubMed ID: 32223464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microenvironmental interactions in classical Hodgkin lymphoma and their role in promoting tumor growth, immune escape and drug resistance.
    Aldinucci D; Celegato M; Casagrande N
    Cancer Lett; 2016 Sep; 380(1):243-52. PubMed ID: 26474544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokines Orchestrating the Natural Killer-Myeloid Cell Crosstalk in the Tumor Microenvironment: Implications for Natural Killer Cell-Based Cancer Immunotherapy.
    Gaggero S; Witt K; Carlsten M; Mitra S
    Front Immunol; 2020; 11():621225. PubMed ID: 33584718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional and metabolic targeting of natural killer cells to solid tumors.
    Wang J; Matosevic S
    Cell Oncol (Dordr); 2020 Aug; 43(4):577-600. PubMed ID: 32488848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and Manipulation of the Crosstalk Between Dendritic and Natural Killer Cells Within the Tumor Microenvironment.
    Jacobs B; Gebel V; Heger L; Grèze V; Schild H; Dudziak D; Ullrich E
    Front Immunol; 2021; 12():670540. PubMed ID: 34054844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor escape mechanisms: potential role of soluble HLA antigens and NK cells activating ligands.
    Campoli M; Ferrone S
    Tissue Antigens; 2008 Oct; 72(4):321-34. PubMed ID: 18700879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin E2 Secreted by Thyroid Cancer Cells Contributes to Immune Escape Through the Suppression of Natural Killer (NK) Cell Cytotoxicity and NK Cell Differentiation.
    Park A; Lee Y; Kim MS; Kang YJ; Park YJ; Jung H; Kim TD; Lee HG; Choi I; Yoon SR
    Front Immunol; 2018; 9():1859. PubMed ID: 30140269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the tumor microenvironment to improve natural killer cell-based immunotherapies: On being in the right place at the right time, with resilience.
    Murray S; Lundqvist A
    Hum Vaccin Immunother; 2016 Mar; 12(3):607-11. PubMed ID: 26402368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signaling pathways and immune evasion mechanisms in classical Hodgkin lymphoma.
    Liu WR; Shipp MA
    Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):310-316. PubMed ID: 29222272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor Microenvironment-Associated Extracellular Matrix Components Regulate NK Cell Function.
    Rossi GR; Trindade ES; Souza-Fonseca-Guimaraes F
    Front Immunol; 2020; 11():73. PubMed ID: 32063906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of T cells in the microenvironment of Hodgkin lymphoma.
    Wein F; Küppers R
    J Leukoc Biol; 2016 Jan; 99(1):45-50. PubMed ID: 26320264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting natural killer cells in cancer immunotherapy.
    Guillerey C; Huntington ND; Smyth MJ
    Nat Immunol; 2016 Aug; 17(9):1025-36. PubMed ID: 27540992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunobiology and pathophysiology of Hodgkin lymphomas.
    Poppema S
    Hematology Am Soc Hematol Educ Program; 2005; ():231-8. PubMed ID: 16304386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tailoring Natural Killer cell immunotherapy to the tumour microenvironment.
    Barrow AD; Colonna M
    Semin Immunol; 2017 Jun; 31():30-36. PubMed ID: 28935344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The classical Hodgkin's lymphoma microenvironment and its role in promoting tumour growth and immune escape.
    Aldinucci D; Gloghini A; Pinto A; De Filippi R; Carbone A
    J Pathol; 2010 Jul; 221(3):248-63. PubMed ID: 20527019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass cytometry of Hodgkin lymphoma reveals a CD4
    Cader FZ; Schackmann RCJ; Hu X; Wienand K; Redd R; Chapuy B; Ouyang J; Paul N; Gjini E; Lipschitz M; Armand P; Wu D; Fromm JR; Neuberg D; Liu XS; Rodig SJ; Shipp MA
    Blood; 2018 Aug; 132(8):825-836. PubMed ID: 29880615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.